R. van der Noll

First-in-Human Phase I Study of GSK2126458, an Oral Pan-Class I Phosphatidylinositol-3-Kinase Inhibitor, in Patients with Advanced Solid Tumor Malignancies

N. Agarwal, J. Schellens, R. Kurzrock, 2015, Clinical Cancer Research.

A Phase I Dose-Escalation Study of the Safety and Pharmacokinetics of Pictilisib in Combination with Erlotinib in Patients with Advanced Solid Tumors.

J. Ware, J. Spoerke, J. Schellens, 2017, The oncologist.

Support systems to guide clinical decision-making in precision oncology: The Cancer Core Europe Molecular Tumor Board Portal

S. Fröhling, J. Lindberg, J. Bergh, 2020, Nature Medicine.

Long-term safety and anti-tumour activity of olaparib monotherapy after combination with carboplatin and paclitaxel in patients with advanced breast, ovarian or fallopian tube cancer

J. Schellens, J. Beijnen, G. Sonke, 2015, British Journal of Cancer.

Effect of inhibition of the FGFR-MAPK signaling pathway on the development of ocular toxicities.

J. Schellens, J. Beijnen, S. Leijen, 2013, Cancer treatment reviews.

The Molecular Tumor Board Portal supports clinical decisions and automated reporting for precision oncology

S. Fröhling, J. Lindberg, J. Bergh, 2022, Nature Cancer.

Phase I and pharmacological trial of lapatinib in combination with gemcitabine in patients with advanced breast cancer

W. M. Smit, J. Schellens, H. Rosing, 2015, Investigational New Drugs.

Support systems to guide clinical decision-making in precision oncology: The Cancer Core Europe Molecular Tumor Board Portal

S. Fröhling, J. Lindberg, J. Bergh, 2020, Nature Medicine.

Phase I first-in-human study of the PI3 kinase inhibitor GSK2126458 (GSK458) in patients with advanced solid tumors (study P3K112826).

J. Schellens, A. Tan, R. Kurzrock, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Abstract LB-122: A phase I dose escalation study of NVP-BGJ398, a selective pan FGFR inhibitor in genetically preselected advanced solid tumors

M. Hidalgo, L. Sequist, R. Camidge, 2012 .